Valneva’s next-gen Zika vaccine shows strong safety and immune response in phase I trial
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Speakers are: Dr. Alok Khullar, Senior Technology Leader, Pidilite Industries; Dr. Kamlesh Pai Fondekar, Head - R&D, Godrej Agrovet; Dr. Hiten Mehta, Head - R&D (Chlor-Alkali), Aditya Birla Chemicals; Dr. Anil Kumar Soni, Head - Application Development, R&D, Clariant Chemicals India; Dr. Rupak Paul, Deputy General Manager – Formulation, Rallis India; Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals; and Pravin Prashant, Executive Editor, Indian Pharma Post
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
AI-powered cardiometabolic wellness platform for India’s workforce
The event will be attended by 35,000+ industry professionals
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Subscribe To Our Newsletter & Stay Updated